Showing results (141-150 of 877) with videos related to

Sort By:
Pageof 88
Clinical Chemistry|October 6, 2010
Importance of biomarkers for long-term mortality prediction in acutely dyspneic patientsJames L Januzzi, Shafiq Rehman, Thomas Mueller, et al.
American Heart Journal|December 15, 2010
Serum albumin and mortality in acutely decompensated heart failureShanmugam Uthamalingam, Jagdesh Kandala, Marilyn Daley, et al.
Journal of the American College of Cardiology|June 17, 2017
Effects of Canagliflozin on Cardiovascular Biomarkers in Older Adults With Type 2 DiabetesJames L Januzzi, Javed Butler, Petr Jarolim, et al.
Journal of the American College of Cardiology|October 26, 2019
Clinical and Prognostic Significance of sST2 in Heart Failure: JACC Review Topic of the WeekAlberto Aimo, James L Januzzi, Antoni Bayes-Genis, et al.
European Journal of Heart Failure|November 17, 2022
Inflammation across universal definition of heart failure stages: the CASABLANCA studyReza Mohebi, Yuxi Liu, Roland van Kimmenade, et al.
Current Diabetes Reports|September 28, 2021
Asymptomatic Diabetic Cardiomyopathy: an Underrecognized Entity in Type 2 DiabetesAna Maria Stanton, Muthiah Vaduganathan, Lee-Shing Chang, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 22, 2013
β-Trace protein: from GFR marker to cardiovascular risk predictorEsteban Orenes-Piñero, Sergio Manzano-Fernández, Ángel López-Cuenca, et al.
Journal of the American Heart Association|May 16, 2022
A Biomarker-Enhanced Model for Prediction of Acute Kidney Injury and Cardiovascular Risk Following Angiographic Procedures: CASABLANCA AKI Prediction SubstudyReza Mohebi, Roland van Kimmenade, Cian McCarthy, et al.
ESC Heart Failure|December 17, 2021
N-terminal pro-B-type natriuretic peptide testing patterns in patients with heart failure with reduced ejection fractionJames L Januzzi, Xi Tan, Lingfeng Yang, et al.
Pageof 88